LY3819253

LY-CoV555 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LY3819253, covering 2021-11-09 to 2023-10-10. Get the full timeline:

Most recent: Clinical Trial Update: LY3819253 (LY-CoV555) for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) [Phase 3]